Key result
Reduced UCP1 expression in periprostatic adipose tissue is linked to higher odds of high-grade prostate cancer.
Why the study?
Periprostatic adipose tissue is recognized as part of the prostate cancer microenvironment, but the role of uncoupling protein 1 in this tissue remains unclear.
Is reduced UCP1 expression in periprostatic adipose tissue associated with high-grade prostate cancer in patients undergoing radical prostatectomy?
Observational (n=83)
Is reduced UCP1 expression in periprostatic adipose tissue associated with high-grade prostate cancer in patients undergoing radical prostatectomy?
Reduced UCP1 expression in periprostatic adipose tissue is independently associated with high-grade prostate cancer, suggesting it may serve as a microenvironment-associated marker of disease severity.
May support biomarker research in prostate cancer; leaves open validation before any clinical use.
Background Periprostatic adipose tissue (PPAT) is increasingly recognized as a component of the prostate cancer (PCa) microenvironment. However, the role of uncoupling protein 1 (UCP1) in PPAT remains unclear. We investigated the association between PCa grade and UCP1 expression in PPAT. Methods After institutional review board approval, we collected PPAT and abdominopelvic adipose tissue (APAT) samples from 83 Japanese patients who underwent robot‐assisted radical prostatectomy for clinically localized PCa. UCP1 mRNA expression in PPAT was quantified by RT‐qPCR and normalized to APAT expression (PPAT/APAT ratio). PPAT volume was estimated by computed tomography. Associations with pathological stage and International Society of Urological Pathology (ISUP) grade were evaluated, and logistic regression was performed to identify factors associated with high‐grade disease (ISUP 4/5). Results In the univariable logistic regression analysis, lower (log‐transformed) UCP1 expression was significantly associated with high‐grade PCa ( ISUP 4/5) (odds ratio [ OR ] 0.415, 95% confidence interval [ CI ] 0.180–0.883, p = 0.027). Age, prostate serum antigen ( PSA ) concentration, and PPAT volume were not significantly associated with high‐grade disease. In the multivariable analysis adjusted for age, PSA concentration, and PPAT volume, UCP1 expression remained independently associated with high‐grade PCa ( OR 0.438, 95% CI 0.188–0.945, p = 0.035). No other clinicopathological variables demonstrated independent associations. Conclusions Reduced UCP1 expression in PPAT was independently associated with high‐grade PCa. PPAT UCP1 expression may represent a microenvironment‐associated marker reflecting PCa severity.
No takes yet. Share an insight, caveat, or question.
Kashiwagi et al. (2026) conducted an observational in Clinically localized prostate cancer (n=83). UCP1 expression in periprostatic adipose tissue was evaluated on High-grade prostate cancer (ISUP 4/5) (OR 0.438, 95% CI 0.188-0.945, p=0.035). Reduced UCP1 expression in periprostatic adipose tissue was independently associated with high-grade prostate cancer (OR 0.438; 95% CI 0.188-0.945; p=0.035).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: